1. Spain Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
Ercros, S.A.

Ercros, S.A.

3.49
EUR
0.00
(0.00%)
-0.31EPS
317.74MMarket Cap
Feb 26Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
6.04
5.48
5.42
5.28
6.07
6.15
6.31
5.54
7.65
10.15
7.73
7.04
6.6
6.66
Basic EPS, GAAP
-0.04
-0.06
0.06
0.4
0.4
0.41
0.29
0.06
0.43
0.64
0.3
-0.13
-0.59
-0.31
Free Cash Flow per Basic Share
0.19
0.03
0.04
0.17
0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
0.04
0.05
0.06
0.05
- -
0.08
0.15
0.1
- -
- -
Book Value per Share
1.61
1.5
1.54
1.93
2.25
2.56
2.78
2.81
3.36
3.83
3.97
3.73
3.14
3.1
Tangible Book Value per Share
1.56
1.45
1.48
1.88
2.21
2.52
2.72
2.74
3.24
3.63
3.75
3.55
2.91
2.87
Basic Weighted Avg Shares
104
110
114
114
112
109
106
103
101
98
91
91
91
91
Sales/Revenue/Turnover
625
604
618
603
681
672
670
569
772
999
707
643
603
609
Operating Margin (%)
1.54
0.03
2.73
6.88
7.08
7.6
5.83
4.21
8.5
11.31
2.24
-0.44
-4.41
-0.95
Depreciation Expense
19
19
20
19
18
26
27
30
28
30
32
31
34
35
Net Income, GAAP
-4
-6
7
45
45
45
31
6
43
63
28
-12
-54
-28
Effective Tax Rate (%)
- -
- -
- -
0.35
- -
- -
- -
10.42
16.69
19.68
- -
- -
- -
- -
Profit Margin (%)
-0.6
-1.04
1.17
7.5
6.54
6.64
4.63
1.1
5.61
6.31
3.9
-1.81
-8.88
-4.64
Working Capital
-13
-24
-4
39
-2
-3
8
27
69
78
45
32
32
-5
LT Debt
56
42
43
59
63
61
73
97
95
104
100
91
138
128
Total Equity
172
168
176
220
247
272
292
284
332
361
363
341
287
283
Return on Invested Capital (%)
- -
- -
- -
15.24
- -
- -
- -
3.03
11.95
15.68
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
14.85
- -
- -
- -
2.37
10.64
13.93
- -
- -
- -
- -
Return on Common Equity (%)
-2.17
-3.7
4.21
22.83
19.09
17.16
11
2.17
14.06
18.2
7.62
-3.31
-17.05
-9.49

Capital Structure

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
85
- -
98
LT Borrowings
130
- -
116
LT Finance Leases
8
20
12
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
91
91
91
Market Capitalization
313
312
318

Working Capital

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
246
183
276
Cash, Cash Equivalents & STI
94
43
66
Accounts Receivable, Net
38
- -
86
Inventories
102
- -
105
Total Current Liabilities
214
125
280
Payables & Accruals
- -
- -
- -
ST Debt
85
- -
98
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.64%
0.85%
-15.8%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
121.1%
159.73%
359.68%
Sales/Revenue/Turnover
1.44%
4.13%
-6.23%
Total Cash Common Dividend
- -
- -
-96.3%

Quarterly Revenue

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
183
177
155
128
643
2025
179
168
146
111
603
2026
150
201
- -
- -
- -

Quarterly Earnings Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
-0.02
-0.1
-0.04
-0.13
2025
-0.13
-0.19
-0.13
-0.14
-0.59
2026
-0.15
0.11
- -
- -
- -

Quarterly Dividends Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.1
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
João Maria Guimaraes José de Mello
Full Time Employees
1,329
Sector
Process industries
Industry
Chemicals: specialty
Address
Avinguda Diagonal, 593-595 Barcelona Spain 08014
IPO Date
Sep 17, 1990
Website
ercros.es
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
PI Industries Limited (NSE:PIIND)
Business
Ercros, S.A. (ECR.MC) manufactures and markets basic chemicals, intermediate chemicals and pharmaceuticals with operations centered in Spain. The company operates through three divisions: Chlorine Derivatives, which produces chlorine, caustic soda and potash, sodium hypochlorite, hydrochloric acid, hydrogen peroxide, dichloroethane, vinyl chloride monomer, PVC compounds, sodium chlorate, chloroisocyanurates, dicalcium phosphate, potassium carbonate, ammonia and bioplastics for water treatment, swimming pools, bleaching, solvents, detergents, inks, animal feed and cooling; Intermediate Chemicals, which manufactures formaldehyde, paraformaldehyde, glues and resins, molding compounds, pentaerythritol, dipentaerythritol and sodium formate for particleboard, laminates, plywood, resins, paints, varnishes, electrical components, tableware and tanning; and Pharmaceuticals, which supplies active ingredients and intermediates including azithromycin, clarithromycin, erythromycins, amlodipine besylate, famotidine, fosfomycin calcium, sodium and trometamol, and fusidic acid for antibiotics, cholesterol-lowering, anti-ulcer and anti-fungal applications. Ercros maintains 10 production facilities across Spain, exports 54% of sales to over 90 countries serving industries such as chemicals, construction, wood, paints, food, pharmaceuticals, electronics, automotive, water treatment and personal care, and employs around 1,335 people. Founded in 1989 through the merger of S.A. Cros—tracing origins to 1817—and Unión Explosivos Río Tinto, S.A., the company is headquartered at Avda. Diagonal 595, Barcelona, Spain, and is listed on the Spanish stock exchanges. Recent developments include the installation of a new photovoltaic plant at Flix to cut CO2 emissions by 800 tonnes annually, capacity expansions at Vila-seca I and Tortosa factories boosting chlorine to 217,000 tonnes/year and formaldehyde output, long-term supply contracts for formaldehyde through 2030 and chlorine extensions, alongside rebuffed takeover bids from Esseco in 2024—withdrawn in August 2025 due to CNMC conditions—and earlier interest from Bondalti, while CNMC scrutiny of potential mergers continues into 2025.